Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.67+0.12 (+4.71%)
Close on Nov 17, 2026Market cap $92.82MP/E –Yield –
Anixa Biosciences total assets
Total assets on the balance sheet at the end of each period.
Anixa Biosciences's total assets was $15.07M at Jul 31, 2026. For fiscal 2025 it was $16.08M, down 25.5% from the year before. Over ten years it grew 5.6% a year on average. The highest annual figure on record is $36.26M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $16.08M | -25.5% |
| FY2024 | Oct 31, 2024 | $21.59M | -15.4% |
| FY2023 | Oct 31, 2023 | $25.52M | -16.1% |
| FY2022 | Oct 31, 2022 | $30.41M | -16.1% |
| FY2021 | Oct 31, 2021 | $36.26M | +283.6% |
| FY2020 | Oct 31, 2020 | $9.45M | +50.2% |
| FY2019 | Oct 31, 2019 | $6.29M | -2.4% |
| FY2018 | Oct 31, 2018 | $6.45M | -26.8% |
| FY2017 | Oct 31, 2017 | $8.81M | +56.6% |
| FY2016 | Oct 31, 2016 | $5.63M | -39.7% |
| FY2015 | Oct 31, 2015 | $9.34M | +3.1% |
| FY2014 | Oct 31, 2014 | $9.06M | +66.5% |
| FY2013 | Oct 31, 2013 | $5.44M | -3.9% |
| FY2012 | Oct 31, 2012 | $5.66M | -34.5% |
| FY2011 | Oct 31, 2011 | $8.65M | -13.9% |
| FY2010 | Oct 31, 2010 | $10.05M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $15.07M | -14.6% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $14.87M | -12.4% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $15.23M | -19.4% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $16.08M | -25.5% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $17.65M | -22.9% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $16.98M | -30.3% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $18.91M | -25.5% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $21.59M | -15.4% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $22.91M | -13.8% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $24.36M | -11.8% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $25.37M | -10.4% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $25.52M | -16.1% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $26.58M | -18.4% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $27.60M | -15.8% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $28.31M | -19.7% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $30.41M | -16.1% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $32.56M | -12.1% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $32.80M | -14.8% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $35.24M | +141.3% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $36.26M | +283.6% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $37.06M | +295.9% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $38.50M | +549.8% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $14.60M | +54.5% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $9.45M | +50.2% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $9.36M | +36.8% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $5.92M | -23.7% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $9.45M | +46.1% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $6.29M | -2.4% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $6.84M | -6.2% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $7.77M | +5.5% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $6.47M | -13.6% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $6.45M | -26.8% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $7.29M | -13.3% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $7.36M | +1.5% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $7.49M | +77.6% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $8.81M | +56.6% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $8.41M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $7.25M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $4.22M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $5.63M | – |
See a number that looks wrong?